In prostate cancer, the determination of the biomarker of the androgen receptor splice variant 7 (AR-V7) has been related to a high profile of aggressiveness, greater resistance to castration and a shorter time of relapse after radical prostatectomy. This evidence concerns the gene AR and prostate carcinoma.